MAZE

NASDAQStock

Maze Therapeutics, Inc.

$51.84+1.39 (+2.75%)

52-Week Range

$7.57
$51.84

Key Stats

Market Cap

2.5B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.47

Volume

518.6K

Avg Volume

463.0K

Performance

1M

+7.16%

3M

+33.39%

6M

+122.95%

YTD

+30.34%

1Y

+358.72%

3Y

+224.98%

5Y

+224.98%

Price Chart

ETF Exposure

MAZE is held by 48 ETFs

ETFFund NameWeight
XPHState Street SPDR S&P Pharmaceuticals ETF2.22%
GURUGlobal X - Guru Index ETF1.77%
SBIOALPS Medical Breakthroughs ETF1.58%
BBCVirtus Biotech Clinical Trials ETF0.97%
PTHInvesco Dorsey Wright Healthcare Momentum ETF0.96%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.59%
PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF0.44%
IHEiShares U.S. Pharmaceuticals ETF0.28%
IWCiShares Micro-Cap ETF0.23%
IBBQInvesco Nasdaq Biotechnology ETF0.19%
BIBProShares - Ultra Nasdaq Biotechnology0.13%
FSMLFranklin Small Cap Enhanced ETF0.12%
IBBiShares Biotechnology ETF0.12%
IWNiShares Russell 2000 Value ETF0.07%
RESMColumbia Research Enhanced Small Cap ETF0.06%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF0.06%
VTWVVanguard Russell 2000 Value ETF0.06%
IWMiShares Russell 2000 ETF0.04%
RSSLGlobal X - Russell 2000 ETF0.03%
VTWOVanguard Russell 2000 ETF0.03%
SCHASchwab U.S. Small-Cap ETF0.03%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.03%
UWMProShares - Ultra Russell20000.03%
URTYProShares - UltraPro Russell20000.02%
ISCBiShares Morningstar Small-Cap ETF0.02%
JKJiShares Morningstar Small-Cap ETF0.02%
AVSUAvantis Responsible U.S. Equity ETF0.01%
VXFVanguard Extended Market ETF0.01%
SMMDiShares Russell 2500 ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
FESMFIDELITY ENHANCED SMALL CAP ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
AVUSAvantis U.S. Equity ETF0.00%
VTWGVanguard Russell 2000 Growth ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%

About MAZE ETF Exposure

Maze Therapeutics, Inc. (MAZE) is held by 48 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.5B, MAZE is a widely held institutional stock. The stock currently trades at $51.84. Investors can gain exposure to MAZE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MAZE, sorted by portfolio weight.